October 22, 2016 7:59 PM ET


Company Overview of miRagen Therapeutics, Inc.

Company Overview

miRagen Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA (miRNA)-targeting therapies to improve human health in disease areas of high unmet medical need. It offers miR-208, a heart-specific miRNA that protects the stressed heart from maladaptive changes and preserves cardiac function; and miR-15/195 inhibitors to reduce heart muscle cell death and promote heart muscle cell regeneration following myocardial infarction or heart attack. The company also provides miR-145, a regulator of vascular smooth muscle cells, which focuses on application in hypertension and other vascular diseases to reduce pathological vascular remodeling and lower blo...

6200 Lookout Road

Suite 100

Boulder, CO 80301

United States

Founded in 2006





Key Executives for miRagen Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Co-Founder and Chairman of The Board
Age: 42
Co-Founder and Member of Scientific Advisory Board
Co-Founder and Member of the Scientific Advisory Board
Age: 71
Co-Founder and Member of Scientific Advisory Board
Age: 76
Compensation as of Fiscal Year 2016.

miRagen Therapeutics, Inc. Key Developments

miRagen Therapeutics, Inc. Announces Board Changes

miRagen Therapeutics, Inc. announced the appointment of Kevin Koch, Ph.D., to the company's Board of Directors. Dr. Koch is a Venture Partner with OrbiMed Advisors, LLC, and brings more than 20 years of drug discovery, translational medicine and clinical development expertise to the company. Before joining OrbiMed Advisors, LLC, Dr. Koch was the Senior Vice President of Drug Discovery, Chemical and Molecular Therapeutics at Biogen where he managed global drug discovery and biomarker development, as well as the immunology and hematology teams. From 1998-2013, Dr. Koch served as the President, Chief Scientific Officer, Board member and Co-Founder of Array BioPharma, Inc. While there, he built a fully-integrated R&D team that oversaw the invention of over 20 clinical development candidates in multiple therapeutic areas. Prior to Array, Dr. Koch held senior positions at Amgen Inc. and Pfizer Central Research. Concurrent with this new appointment, Marvin H. Caruthers, Ph.D., is leaving the Board of Directors and is joining the company's Scientific Advisory Board.

miRagen Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-16-2016 12:45 PM

miRagen Therapeutics, Inc. Presents at Wedbush PacGrow Healthcare Conference 2016, Aug-16-2016 12:45 PM. Venue: Le Parker Meridien, New York, New York, United States. Speakers: William S. Marshall, Co-Founder, Chief Executive Officer, President and Director.

miRagen Therapeutics, Inc. Presents at 36th Annual Canaccord Genuity Growth Conference 2016, Aug-10-2016 02:30 PM

miRagen Therapeutics, Inc. Presents at 36th Annual Canaccord Genuity Growth Conference 2016, Aug-10-2016 02:30 PM. Venue: InterContinental Hotel, Boston, Massachusetts, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
October 30, 2015

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact miRagen Therapeutics, Inc., please visit www.miragentherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.